axicabtagene ciloleucel
gilead,daiichi sankyo
['lymphoma', 'axicel']
axicel in r/r in cns lymphoma. no bridging but stable steroid doses allowed. 44% icans, 33% grade 3. cr 67% but median time to best response 3m. mdor and mpfs 11 m. encouraging results presented by caron jacobson. #ash22 
hematologa en Fleming, lymphoma fan, mama de Luchi, un poco yogi y mucha acuarela!